Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Crescent Biopharma, Inc. (CBIO)

Autolus Therapeutics PLC Sponsored ADR and Crescent Biopharma, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Crescent Biopharma, Inc. are of similar size ($463.6M and $457.8M). Autolus Therapeutics PLC Sponsored ADR grew revenue faster over the last twelve months: 193.3% against −45.1%. Crescent Biopharma, Inc. has the higher net margin (0.00% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Crescent Biopharma, Inc. leads on 12 and Autolus Therapeutics PLC Sponsored ADR on 5.

Valuation

Metric AUTL CBIO Biotechnology median
P/E n/m n/m 8.50
P/S 3.63 296.75 9.71
P/B 5.69 2.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.56 186.66 9.21
Earnings yield (66.25%) (56.76%) (33.15%)
Free cash flow yield (59.62%) (19.88%) (25.50%)

Profitability

Metric AUTL CBIO Biotechnology median
Gross margin 15.66% 19.72% 65.16%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (112.14%) (56.36%)
Return on assets (46.15%) (97.08%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL CBIO Biotechnology median
Revenue growth (TTM) 193.29% (45.09%) 6.02%
EPS growth (last fiscal year) (25.58%) 44.97% 30.26%
Revenue growth, 5-year CAGR 113.11% 257.77% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL CBIO Biotechnology median
Debt to equity 1.04 0.00 0.00
Current ratio 4.89 9.66 4.72
Net debt to EBITDA 1.16 1.40 0.96

Dividend

Metric AUTL CBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AUTL CBIO Biotechnology median
Market cap 457.80m 463.56m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack